Please login to the form below
The Gallery
Want to know which agency did which ad? Search using one of the options below.
Agency:
VCCP Health
Product:
Simponi
Client:
Merck Sharp & Dohme
Therapy area:
Musculo-skeletal Disorders
Agency:
VCCP Health
Product:
Simponi
Client:
Merck Sharp & Dohme
Therapy area:
Musculo-skeletal Disorders
Agency:
BASTARD . LONDON
Product:
Self Promotion
Client:
Self Promotion
Therapy area:
Self Promotion
Agency:
BASTARD . LONDON
Product:
Self Promotion
Client:
Self Promotion
Therapy area:
Ear, nose and throat
Agency:
Apex.co.uk Conferences, Events and Exhibition Stands
Product:
Self Promotion
Client:
Self Promotion
Therapy area:
Eye
Featured jobs
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
-
Senior Medical Writer
-
Great salary and benefits
-
Project Manager/ Account Manager
-
Salary TBC
-
Senior Medical Writer
-
Up to £50, 000 with Benefits
-
Digital Account Director
-
Salary TBC
-
Senior Medical Writer
-
Salary TBC
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
-
Account Director, Medical Education
-
Salary TBC
Subscribe to our email news alerts
- Immuno-oncology in 2019: the rapid evolution continues
- Lucid Group acquires digital and creative agency Bluedog
- ‘Love looks not with the eyes but with the mind’
- Novartis’ Egatan gains US approval for neglected tropical disease
- Lucid Group brings creative and digital magic to the mix with the acquisition of Bluedog
- Lucid Group acquires creative and digital agency Bluedog
PMHub
Nobull Communications
Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...
Latest intelligence
- Immuno-oncology in 2019: the rapid evolution continues
- Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
- Mixing up Focus Groups
- A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...
- Immunotherapy combination trials Q&A
- By Chris Learn and Martin Lachs...
Quick links
Infographics
